Pharmacy

Systolic and diastolic arterial pressure measurement recorded in the context of drug therapy monitoring. Used in clinical systems to assess cardiovascular response to medications, track contraindications, and document baseline or ongoing vitals during pharmacological treatment.

The calendar date on which a prescribed or ordered drug was cancelled before completion of the intended therapy course. Captured in pharmacy and EHR systems to document discontinuation events, support medication reconciliation, and maintain an accurate active medication list for the patient.

A classification label assigned to a drug within provider and pharmacy systems, used to group medications by therapeutic use, formulary tier, or administrative type. Supports formulary management, utilization reporting, PBM integrations, and downstream analytics in healthcare data platforms.

The gross billed dollar amount associated with dispensing or administering a specific drug prior to adjustments, discounts, or payer reductions. Used in pharmacy billing and claims processing to establish the initial charge submitted to insurance or recorded in revenue cycle management systems.

The primary symptom or clinical concern reported by a patient that is directly associated with a drug therapy encounter or adverse drug event. Captured in clinical documentation to link presenting complaints to medication-related diagnoses, side effects, or therapeutic interventions in the patient record.

Represents a subordinate drug record in a parent-child hierarchy within pharmacy or formulary drug master files. Used in EHR and PBM systems to link branded drugs to generics, or drug families to specific NDC codes, supporting formulary substitution and drug relationship analytics.

The municipality name associated with the location where a drug is dispensed, manufactured, or where the prescribing encounter occurred. Used in pharmacy records and regulatory reporting to identify geographic distribution points, support drug diversion tracking, and fulfill DEA reporting requirements.

A standardized classification tier assigned to a pharmaceutical compound based on its pharmacological or therapeutic properties, such as therapeutic class codes in Medi-Span or First Databank. Used in EHR, PBM, and claims systems for utilization management, formulary design, and analytics.

A standardized code identifying the therapeutic class or pharmacological category of a prescription drug, used in pharmacy benefit management for formulary organization, drug utilization review, clinical editing, and pharmacy analytics segmenting drug spend and utilization by therapeutic area. Common drug classification systems include GPI, Medi-Span, First Databank, and AHFS pharmacological classification with hierarchical structures from broad therapeutic category to specific drug ingredient.

A standardized identifier, such as NDC, RxNorm, or GPI code, assigned to a drug within pharmacy dispensing, PBM adjudication, and claims processing systems. Used for drug identification, formulary lookups, clinical decision support, and cross-system reporting in healthcare data pipelines.

The portion of a drug's total cost that a member is responsible for paying after the deductible is met, calculated as a percentage of the allowed amount. Captured in pharmacy claims and benefit administration systems to determine member cost-sharing obligations under prescription drug plan benefit structures.

Free-text annotation field attached to a drug record in pharmacy, EHR, or drug master file systems. Captures clinical notes, dispensing instructions, formulary exceptions, or administrative remarks. Used for data quality review, clinical documentation audits, and supplemental reporting in healthcare platforms.

The calendar date on which a patient completed the full prescribed course of drug therapy. Recorded in pharmacy and clinical systems to confirm therapeutic course adherence, support medication reconciliation, and trigger follow-up clinical assessments or lab monitoring as required by the treatment protocol.

A flag designating that a drug record contains sensitive or protected information requiring restricted access, such as medications related to mental health, substance use disorder, or HIV treatment. Used in EHR and pharmacy systems to enforce privacy rules under 42 CFR Part 2 and applicable state confidentiality laws.

The designated communication reference point for a drug record, such as a manufacturer, pharmacy, or clinical contact stored in drug master files or PBM systems. Used in healthcare data systems for vendor management, adverse event reporting, and drug recall notification workflows.

The fixed out-of-pocket dollar amount a member pays at the point of dispensing for a specific drug under their prescription benefit plan. Captured in pharmacy claims and adjudication systems to apply benefit tier structures, track member cost-sharing, and calculate total plan liability for drug spend reporting.

The actual acquisition or reimbursement cost associated with a specific drug, reflecting the amount paid by a plan, pharmacy, or healthcare entity after all adjustments and discounts. Used in pharmacy financial reporting, formulary management, and drug utilization analysis to evaluate medication spend and cost-effectiveness.

The annual percentage rate of increase in prescription drug prices, including brand-name price list increases, specialty drug launch prices, and generic drug market dynamics, representing the price component of pharmacy benefit cost trend. Brand-name drug price inflation has historically exceeded general medical inflation with list price increases averaging 5-10% annually before rebates. Drug cost inflation analytics inform pharmacy benefit actuarial modeling and premium rate development.

The average total pharmacy claim cost including ingredient cost and dispensing fee divided by the number of pharmacy claims, used as a unit cost metric in pharmacy benefit analytics to track drug cost trends, compare costs across formulary tiers, and benchmark pharmacy network performance. Drug cost per claim trends are decomposed into unit cost changes from drug price inflation and mix changes from shifts in the distribution of claims across therapeutic categories.

The total number of occurrences or instances of a specific drug compound recorded in pharmacy dispensing, claims adjudication, or EHR medication administration systems. Used in utilization analytics, prescription volume reporting, formulary audits, and PBM performance measurement dashboards.